Montelukast Sodium Tablet, Chewable
Product Images NDC 42291-622

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 42291-622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

621 10 Montelukast

Montelukast Sodium Tablets 10 mg packaging label by AvKARE. The label indicates the strength as 10 mg, directed for adults aged 15 years and older, containing 1000 tablets. It includes storage and usage instructions along with the NDC number 42291-621-10 and manufacturer details.*

FDA Label Image

Label 4229162290 Montelukast Sodium 2016 4mg Chewable

Montelukast Sodium Chewable Tablets 4 mg for pediatric patients aged 2-5 years, labeled by AvKARE. The label indicates a package containing 90 chewable tablets with instructions for pharmacists to dispense an attached patient leaflet. Storage and dosage information is also included.*

FDA Label Image

Label 4229162390 Montelukast Sodium 2018 5mg Chewable

Montelukast Sodium 5 mg chewable tablets packaging label by AvKARE. The product is intended for pediatric patients aged 6 to 14 years. The label indicates 90 tablets per package, marked as prescription only (Rx Only). The label includes instructions for dispensing and storage conditions, along with manufacturer details and a barcode.*

FDA Label Image

Montelukast Sodium Tablets And Chewable Tablets 1

A line graph showing change in height (cm) over weeks on treatment for Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo groups. The x-axis represents weeks on treatment from -19 to 56, and the y-axis shows change in height from -3 to 7 cm. Data points and lines compare growth trends across the three treatments.*

FDA Label Image

Montelukast Sodium Tablets And Chewable Tablets 2

Chemical structure of Montelukast Sodium. The image displays the molecular diagram including a chlorinated quinoline ring, cyclopropane carboxylate sodium salt moiety, and other characteristic aromatic and aliphatic groups.*

FDA Label Image

Montelukast Sodium Tablets And Chewable Tablets 3

A line graph comparing mean percent change from baseline over weeks in treatment for Montelukast Sodium versus placebo. The x-axis represents weeks in treatment from 0 to 15, including a 1-week washout period. The y-axis shows mean percent change from baseline. Montelukast Sodium shows higher mean percent change values than placebo throughout treatment, with data points and error bars displayed for both groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.